Q1: 2026-04-29 Earnings Summary
EPS of $2.65 misses by $0.02
| Revenue of $15.00B (12.43% Y/Y) beats by $283.38M
AbbVie Inc. (ABBV) Q1 2026 Earnings Call April 29, 2026 9:00 AM EDT
Company Participants
Elizabeth Shea - Senior Vice President of Investor Relations
Robert Michael - CEO & Chairman of the Board
Jeffrey Stewart - Executive VP & Chief Commercial Officer
Roopal Thakkar - Executive VP of Research & Development and Chief Scientific Officer
Scott Reents - Executive VP & CFO
Conference Call Participants
David Amsellem - Piper Sandler & Co., Research Division
Christopher Schott - JPMorgan Chase & Co, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Louise Chen - Scotiabank Global Banking and Markets, Research Division
Terence Flynn - Morgan Stanley, Research Division
Trung Huynh - RBC Capital Markets, Research Division
James Shin - Deutsche Bank AG, Research Division
Gary Nachman - Canaccord Genuity Corp., Research Division
Vamil Divan - Guggenheim Securities, LLC, Research Division
Asad Haider - Goldman Sachs Group, Inc., Research Division
David Risinger - Leerink Partners LLC, Research Division
Steve Scala - TD Cowen, Research Division
Presentation
Operator
Good morning, and thank you for standing by. Welcome to the AbbVie First Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time.
I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations.
Elizabeth Shea
Senior Vice President of Investor Relations
Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research and Development and Chief Financial (sic) [ Scientific ] Officer; and Scott Reents, Executive Vice President and Chief Financial Officer.
Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on our current expectations. AbbVie cautions that these forward-looking statements are subject to risks and
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。